Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma

Aman M, Murasaki Aman, Ohishi Y, Yoshihiro Ohishi, Hiroko Imamura, Imamura H, Tomoko Shinozaki, Shinozaki T, Yasutake N, Nobuko Yasutake, Kiyoko Kato, Kato K, Yoshinao Oda, Oda Y
Human pathology · 2017 · vol. 64 , pp. 156–163 · doi:10.1016/j.humpath.2017.04.008 · PMID:28438620 · W2606122885
article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

Protease-activated receptor-2 (PAR-2) expression correlated with advanced clinical stage and poorer prognosis in ovarian clear cell carcinoma.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Recent studies demonstrated that protease-activated receptor-2 (PAR-2) correlates with tumor progression in various tissues. On the other hand, oxidative stress arising from endometriosis has been considered a cause of carcinogenesis in ovarian clear cell carcinoma (OCCC). We previously demonstrated that oxidative stress up-regulates PAR-2 expression, and we conducted the present study to investigate the PAR-2 expression and its relation to clinicopathological factors and oxidative stress in OCCC. We performed an immunohistochemical evaluation in 95 cases of OCCC. For the evaluation of oxidative stress markers, 31 cases of ovarian endometrioid carcinoma (OEC) were also examined. No significant differences in the expression of cyclooxygenase-2 and inducible nitric oxide synthase were observed between OCCC and OEC. Sixty-two percent of the OCCC cases showed high 8-hydroxydeoxyguanosine expression, whereas all of the OEC cases showed almost negative immunoreactivities. The presence of endometriosis did not affect the expression of these oxidative stress markers or prognosis. High PAR-2 expression was observed in 20% (14/71) of the early International Federation of Gynecology and Obstetrics (FIGO) stage cases and 58% (14/24) of the advanced FIGO stage cases. High PAR-2 expression was significantly correlated with advanced FIGO stage and shorter overall survival. We found no correlations between PAR-2 expression and oxidative stress in OCCC. Our results suggest that PAR-2 plays an important role in the progression of OCCC. The expression of 8-hydroxydeoxyguanosine is a characteristic finding of OCCC, indicating that the injury of DNA by oxidative stress may be involved in the carcinogenesis of OCCC.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Biomarkers, Tumor Carcinoma Ovarian Neoplasms Receptors, G-Protein-Coupled 8-Hydroxy-2'-Deoxyguanosine Biomarkers, Tumor Biopsy Carcinoma Carcinoma Carcinoma Carcinoma Deoxyguanosine Deoxyguanosine Deoxyguanosine Disease Progression DNA Damage Endometriosis Endometriosis Endometriosis Female

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

Cited by (2)

References (34)

Cited by (2)

Source provenance

europepmc
last seen: 2026-10-02T06:17:20.788884+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:20:31.759405+00:00
unpaywall
last seen: 2026-10-02T06:31:42.897446+00:00
License: CC0 · commercial use OK